ReviewHematology. American Society of Hematology. Education Program2024
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient.
Michael Heuser et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it